Evidence is also emerging indicating that PDK1 inhibition can impact on several cellular functions associated with cancer progression, such as reduced invasion on Matrigel of breast, prostate and melanoma cancer cell lines [13–15]. This evidence concerns the gene PDK1 and cancer.